{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T16:34:59Z","timestamp":1783355699991,"version":"3.54.6"},"reference-count":49,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Cancer"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Disparities in cancer burden between transgender and cisgender individuals remain an underexplored area of research.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n This study aimed to examine the cumulative incidence and associated risk factors for cancer and precancerous conditions among transgender individuals compared with matched cisgender individuals.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n We conducted a retrospective cohort study using patient-level electronic health record (EHR) data from the University of Florida Health Integrated Data Repository between 2012 and 2023. Transgender individuals were identified using a validated, computable phenotype algorithm that used structured data and clinical notes. They matched 1:10:10 by age and calendar year of index date with cisgender women and cisgender men. The index date was the first transgender-related record for transgender individuals and a matched diagnosis date for cisgender controls. Primary outcomes included new-onset cancers associated with human papillomavirus, human immunodeficiency virus, tobacco, alcohol, lung, breast, and colorectal sites. Secondary outcomes were precancerous conditions related to the same cancer types. We calculated cumulative incidence rates and conducted time-to-event analyses using the Fine-Gray method, treating all-cause death as a competing risk, to assess associations between gender identity and the presence of cancer or precancer, adjusting for demographic and clinical covariates. Interaction analyses evaluated if associations between cancer risk factors and precancer differed by gender identity.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n We identified 2745 transgender individuals (mean age at index date 25.1, SD 14.0 years) and matched them with 27,450 cisgender women and 27,450 cisgender men from the same health care system. The cumulative incidence of cancer did not differ significantly between transgender and cisgender cohorts (transgender n=28, 1.0% vs cisgender women, n=358, 1.3%;\n P<\/jats:italic>\n =.13 and cisgender men, n=314, 1.1%;\n P<\/jats:italic>\n =.64). However, transgender individuals exhibited significantly higher risks for precancerous conditions compared to cisgender women (subdistribution hazard ratios [sHRs] 1.1, 95% CI 1.0\u20101.3) and cisgender men (sHR 1.3; 95% CI 1.2\u20101.5). Specifically, transgender individuals were more likely to develop colorectal precancer (sHR 1.2; 95% CI 1.1\u20101.4) compared to cisgender women, as well as human papillomavirus\u2013related precancer (sHR 1.8; 95% CI 1.4\u20102.3) and colorectal precancer (sHR 1.4; 95% CI 1.2\u20101.6) compared to cisgender men. Subgroup analyses showed similar patterns in both female-to-male and male-to-female individuals compared with their matched cisgender counterparts. Interaction analyses revealed stronger protective effects of private insurance or Medicare against precancers in transgender individuals than in cisgender peers, while being non-Hispanic Black or having substantial comorbidities were stronger risk factors among transgender individuals.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Transgender individuals showed a similar cancer incidence yet significantly higher precancer incidence compared with cisgender individuals, suggesting underdiagnosis or delayed detection. These findings highlight the need for tailored preventive care strategies, including targeted screenings and risk reduction interventions, to address cancer disparities in the transgender population.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/73843","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T21:44:17Z","timestamp":1757367857000},"page":"e73843-e73843","source":"Crossref","is-referenced-by-count":1,"title":["The Burden of Cancer and Precancerous Conditions Among Transgender Individuals in a Large Health Care Network: Retrospective Cohort Study"],"prefix":"10.2196","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9890-7668","authenticated-orcid":false,"given":"Shuang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9661-3381","authenticated-orcid":false,"given":"Yongqiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0452-0252","authenticated-orcid":false,"given":"Christopher W","family":"Wheldon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3690-3848","authenticated-orcid":false,"given":"Jessica Y","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9021-5595","authenticated-orcid":false,"given":"Mattia","family":"Prosperi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6249-9180","authenticated-orcid":false,"given":"Thomas J","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4903-1804","authenticated-orcid":false,"given":"Elizabeth A","family":"Shenkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9459-9461","authenticated-orcid":false,"given":"Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2238-5429","authenticated-orcid":false,"given":"Jiang","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0587-4105","authenticated-orcid":false,"given":"Yi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2025,9,8]]},"reference":[{"issue":"9","key":"R1","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1037\/a0039906","article-title":"Guidelines for psychological practice with transgender and gender nonconforming people","volume":"70","author":"American Psychological Association","journal-title":"Am Psychol"},{"issue":"2","key":"R2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/26895269.2020.1753136","article-title":"Epidemiological considerations in transgender health: a systematic review with focus on higher quality data","volume":"21","author":"Zhang","journal-title":"Int J Transgend Health"},{"key":"R3","unstructured":"Parker K . Americans\u2019 complex views on gender identity and transgender issues. Pew Research Center. 2022. URL: https:\/\/www.pewresearch.org\/social-trends\/2022\/06\/28\/americans-complex-views-on-gender-identity-and-transgender-issues\/ [Accessed 22-02-2024]"},{"issue":"10042","key":"R4","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/S0140-6736(16)00684-X","article-title":"Global health burden and needs of transgender populations: a review","volume":"388","author":"Reisner","journal-title":"Lancet"},{"key":"R5","doi-asserted-by":"crossref","unstructured":"Landers S . Risk for cancer in gay, bisexual and transgender men via infection cancer and the LGBT community. In: Cancer and the LGBT Community. Springer International Publishing; 2015:7-21. ISBN: 9783319150567","DOI":"10.1007\/978-3-319-15057-4_2"},{"issue":"16","key":"R6","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00439-8","article-title":"Cancer in the transgender community","volume":"16","author":"Loughlin","journal-title":"Lancet Oncol"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l1652","article-title":"Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands","volume":"365","author":"de Blok","journal-title":"BMJ"},{"issue":"1","key":"R8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10549-014-3213-2","article-title":"Incidence of breast cancer in a cohort of 5,135 transgender veterans","volume":"149","author":"Brown","journal-title":"Breast Cancer Res Treat"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2018.02.008","article-title":"Frequency and distribution of primary site among gender minority cancer patients: an analysis of U.S. national surveillance data","volume":"54","author":"Nash","journal-title":"Cancer Epidemiol"},{"issue":"4","key":"R10","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1001\/jamaoncol.2022.7173","article-title":"Cancer in transgender and gender-diverse persons: a review","volume":"9","author":"Leone","journal-title":"JAMA Oncol"},{"issue":"11","key":"R11","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1111\/aogs.14686","article-title":"Cancer risk among transgender adults: a growing population with unmet needs","volume":"102","author":"Jackson","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"5","key":"R12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/bcr628","article-title":"Oestrogen exposure and breast cancer risk","volume":"5","author":"Travis","journal-title":"Breast Cancer Res"},{"issue":"4","key":"R13","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.trecan.2022.01.005","article-title":"Understanding the role of sex hormones in cancer for the transgender community","volume":"8","author":"Jackson","journal-title":"Trends Cancer"},{"issue":"6","key":"R14","doi-asserted-by":"publisher","first-page":"877","DOI":"10.21037\/tau.2016.09.04","article-title":"Hormone therapy for transgender patients","volume":"5","author":"Unger","journal-title":"Transl Androl Urol"},{"issue":"1","key":"R15","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.amepre.2016.11.022","article-title":"Transgender use of cigarettes, cigars, and e-cigarettes in a national study","volume":"53","author":"Buchting","journal-title":"Am J Prev Med"},{"issue":"1","key":"R16","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.drugalcdep.2018.01.016","article-title":"Alcohol research with transgender populations: a systematic review and recommendations to strengthen future studies","volume":"186","author":"Gilbert","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"R17","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1089\/lgbt.2023.0335","article-title":"Prevalence and determinants of cervicovaginal, oral, and anal human papillomavirus infection in a population of transgender and gender diverse people assigned female at birth","volume":"11","author":"McIntosh","journal-title":"LGBT Health"},{"issue":"12","key":"R18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0260063","article-title":"The worldwide burden of HIV in transgender individuals: an updated systematic review and meta-analysis","volume":"16","author":"Stutterheim","journal-title":"PLoS ONE"},{"issue":"6","key":"R19","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.21037\/tau-20-954","article-title":"Cancer screening in the transgender population: a review of current guidelines, best practices, and a proposed care model","volume":"9","author":"Sterling","journal-title":"Transl Androl Urol"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2020.106071","article-title":"Barriers and facilitators to cervical cancer screening among transgender men and non-binary people with a cervix: a systematic narrative review","volume":"135","author":"Connolly","journal-title":"Prev Med"},{"issue":"7","key":"R21","doi-asserted-by":"publisher","first-page":"265","DOI":"10.5306\/wjco.v14.i7.265","article-title":"Cancer screening and management in the transgender population: review of literature and special considerations for gender affirmation surgery","volume":"14","author":"Panichella","journal-title":"World J Clin Oncol"},{"issue":"3","key":"R22","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1089\/trgh.2020.0017","article-title":"Health care access and utilization by transgender populations: a United States transgender survey study","volume":"5","author":"Kachen","journal-title":"Transgend Health"},{"issue":"2","key":"R23","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/MED.0000000000000227","article-title":"Barriers to healthcare for transgender individuals","volume":"23","author":"Safer","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"1","key":"R24","doi-asserted-by":"publisher","DOI":"10.52504\/001c.29779","article-title":"Addressing the disparities transgender patients face in the US health care system","volume":"5","author":"Al-Hiraki","journal-title":"Georgetown Medical Review"},{"key":"R25","unstructured":"Precancerous. Canadian Cancer Society. URL: https:\/\/cancer.ca\/en\/cancer-information\/resources\/glossary\/p\/precancerous [Accessed 28-02-2024]"},{"key":"R26","doi-asserted-by":"crossref","unstructured":"Salcedo MP Phoolcharoen N Schmeler KM . Intraepithelial neoplasia of the lower genital tract (cervix, vagina, vulva). In: Comprehensive Gynecology. Elsevier; 2022:637-647. ISBN: 9780323653992","DOI":"10.1016\/B978-0-323-65399-2.00038-3"},{"issue":"1","key":"R27","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ygyno.2020.01.023","article-title":"The risk of cervical cancer after cervical intraepithelial neoplasia grade 3: a population-based cohort study with 80,442 women","volume":"157","author":"Loopik","journal-title":"Gynecol Oncol"},{"key":"R28","volume":"2020","author":"Guo","journal-title":"AMIA Annu Symp Proc"},{"issue":"732","key":"R29","doi-asserted-by":"publisher","first-page":"e486","DOI":"10.3399\/BJGP.2023.0023","article-title":"Prevalence of cancer risk factors among transgender and gender diverse individuals: a cross-sectional analysis using UK primary care data","volume":"73","author":"Brown","journal-title":"Br J Gen Pract"},{"issue":"1","key":"R30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/epirev\/mxw003","article-title":"Cancer in transgender people: evidence and methodological considerations","volume":"39","author":"Braun","journal-title":"Epidemiol Rev"},{"key":"R31","unstructured":"HPV and cancer. National Cancer Institute. 2019. URL: https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/infectious-agents\/hpv-and-cancer [Accessed 06-03-2024]"},{"key":"R32","unstructured":"HIV and cancer. American Cancer Society. URL: https:\/\/www.cancer.org\/cancer\/risk-prevention\/infections\/hiv-infection-aids\/hiv-aids-and-cancer.html [Accessed 06-03-2024]"},{"key":"R33","unstructured":"Alcohol and cancer risk. National Cancer Institute. 2021. URL: https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/alcohol\/alcohol-fact-sheet [Accessed 06-03-2024]"},{"key":"R34","unstructured":"Tobacco. National Cancer Institute. 2015. URL: https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/tobacco [Accessed 06-03-2024]"},{"issue":"12","key":"R35","doi-asserted-by":"publisher","first-page":"866","DOI":"10.12998\/wjcc.v2.i12.866","article-title":"Precancerous lesions of oral mucosa","volume":"2","author":"Yardimci","journal-title":"World J Clin Cases"},{"issue":"1","key":"R36","doi-asserted-by":"publisher","DOI":"10.1186\/rr170","article-title":"Preneoplastic lesions of the lung","volume":"3","author":"Greenberg","journal-title":"Respir Res"},{"issue":"3","key":"R37","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/PAT.0b013e32835f6169","article-title":"Premalignant lesions of the urinary bladder","volume":"45","author":"Samaratunga","journal-title":"Pathology (Phila)"},{"issue":"12","key":"R38","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.3748\/wjg.v22.i12.3305","article-title":"Latest developments in precancerous lesions of hepatocellular carcinoma","volume":"22","author":"Niu","journal-title":"World J Gastroenterol"},{"issue":"6","key":"R39","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20212516","article-title":"Histomorphological and ultrastructural cadmium-induced kidney injuries and precancerous lesions in rats and screening for biomarkers","volume":"42","author":"Wan","journal-title":"Biosci Rep"},{"issue":"1","key":"R40","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1053\/j.ackd.2013.10.001","article-title":"Hereditary kidney cancer syndromes","volume":"21","author":"Haas","journal-title":"Adv Chronic Kidney Dis"},{"issue":"4","key":"R41","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1159\/000319451","article-title":"Precancerous lesions of the breast","volume":"5","author":"Lebeau","journal-title":"Breast Care (Basel)"},{"issue":"8","key":"R42","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.2105\/AJPH.2012.301182","article-title":"Prevalence of anogenital warts among participants in private health plans in the United States, 2003\u20132010: potential impact of human papillomavirus vaccination","volume":"103","author":"Flagg","journal-title":"Am J Public Health"},{"issue":"8 Suppl","key":"R43","doi-asserted-by":"publisher","first-page":"IV","DOI":"10.1097\/00005650-200208001-00004","article-title":"Assessing comorbidity using claims data: an overview","volume":"40","author":"Klabunde","journal-title":"Med Care"},{"key":"R44","unstructured":"Types of study review by the IRB. University of Florida-Institutional Review Board. URL: https:\/\/irb.ufl.edu\/irb02\/forms-templates-guidelines\/irbrev.html [Accessed 04-09-2025]"},{"key":"R45","unstructured":"Age and cancer risk. National Cancer Institute. 2015. URL: https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/age [Accessed 13-03-2024]"},{"issue":"1","key":"R46","first-page":"e30","volume":"65","author":"Kiran","journal-title":"Can Fam Physician"},{"issue":"6","key":"R47","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1136\/bmjebm-2023-112719","article-title":"Cancer screening attendance rates in transgender and gender-diverse patients: a systematic review and meta-analysis","volume":"29","author":"Chan","journal-title":"BMJ EBM"},{"issue":"3","key":"R48","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.amepre.2019.04.010","article-title":"Breast, cervical, and colorectal cancer screening: patterns among women with Medicaid and commercial insurance","volume":"57","author":"Bonafede","journal-title":"Am J Prev Med"},{"key":"R49","unstructured":"James SE Herman J Keisling M Mottet L Anafi M . 2015 U.S. transgender survey (USTS). Inter-university Consortium for Political and Social Research; 2019. URL: https:\/\/doi.org\/10.3886\/ICPSR37229.v1 [Accessed 02-09-2025]"}],"container-title":["JMIR Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cancer.jmir.org\/2025\/1\/e73843","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:04:44Z","timestamp":1782842684000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancer.jmir.org\/2025\/1\/e73843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,8]]},"references-count":49,"URL":"https:\/\/doi.org\/10.2196\/73843","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.03.24.24304777","asserted-by":"object"}]},"ISSN":["2369-1999"],"issn-type":[{"value":"2369-1999","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,8]]},"article-number":"v11i9e73843"}}